Daphne B. Stewart, M.D., M.S.
2015, Medical Oncology
2015, Hematology
2012, Internal Medicine
2008, M.S., David Geffen School of Medicine at UCLA, Los Angeles, CA
1998, M.D., Columbia University, College of Physicians and Surgeons, New York, NY
1993, B.A., English, with honors, University of California Berkeley, Berkeley, CA
2002-2005, Fellowship: Hematology-Oncology, David Geffen School of Medicine, UCLA, Los Angeles, CA
1999-2002, Residency in Internal Medicine, UCLA, Center for Health Sciences, Los Angeles, CA
1999-2000, Internship in Internal Medicine, UCLA, Center for Health Sciences, Los Angeles, CA
1998-1999, Internship in Obstetrics and Gynecology, Los Angeles County+USC Medical Center, Los Angeles, CA
2018-present, Associate Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
2013-2017, Associate Clinical Professor and Staff Physician, Department of Medical Oncology & Therapeutics Research, City of Hope, South Pasadena, CA
2011-2013, Associate Program Director, Olive View-UCLA and Cedars Sinai Hematology-Oncology Fellowship, Olive View-UCLA Medical Center, Los Angeles, CA
2008-2013, Physician Specialist Hematologist-Oncologist, Department of Medicine, Division of Hematology-Oncology, Olive View-UCLA Medical Center, Los Angeles, CA
2005-2008, Associate Director, Blood and Marrow Transplant Program, Cedars Sinai Medical Center, Los Angeles, CA
2004, American Society of Clinical Oncology
2003, American Society of Hematology
-
Liu J, Gutierrez E, Tiwari A, Padam S, Li D, Dale W, Pal SK, Stewart D, Subbiah S, Bosserman LD, Presant C, Phillips T, Yap K, Hill A, Bhatt G, Yeon C, Cianfrocca M, Yuan Y, Mortimer J, Sedrak MS. Strategies to Improve Participation of Older Adults in Cancer Research. J. Clin. Med. 2020, 9, 1571.
-
Mortimer JE, Kruper L, Jung J, Wong L, Cooper J, Stewart D, Chung S, Yu KW, Dadwal S, Yuan Y. Characterization of infections and hypogammaglobulinemia treated with the combination of pertuzumab and trastuzumab. Cancer Chemotherapy and Pharmacology, 85(3), March 2020, 501-507
-
Stewart D, Cristea M. Antibody-drug conjugates for ovarian cancer: current clinical development. Curr Opin Obstet Gynecol. 2019;31(1):18-23.Nowak D, Stewart D, Koeffler HP. Differentiation therapy of leukemia: Three decades of development. Blood. 2009;113(16):3655-3665.
- Jahan R, Stewart D, Vintners J, Yong W, Vinuela F, Vandenber P, Marder VJ. "Middle cerebral artery occlusion in the rabbit using selective angiography. Application for assessment of thrombolysis." Stroke. 2008; 39(5):1613-1615.
- Stewart D, Marder VJ, Starkman S, Saver J. "Magnesium sulfate neither potentiates nor inhibits tissue plasminogen activator-induced clot lysis." Journal of Thrombosis and Hemostasis. 2006; 4(7): 1575-1579
- Stewart D, Kong M, Novokhatny V, Jesmok G, Marder VJ. "Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage." Blood. 2003; 101(8): 3002-3007
- Sadeghi S, Marder VJ, Stewart D, Kong M, Humphries J, Baumbach G, Jesmok G. "Safety of plasmin in the setting of concomitant aspirin and heparin administration in a rabbit model of bleeding." Journal of Thrombosis and Hemostasis. 2003; 1(12): 2621-2625.
- Haramaki N, Stewart D, Packer L. "Networking antioxidants in the isolated rat heart are selectively depleted by ischemia-reperfusion." Free Radical Biology in Medicine. 1998; 25(3): 329-339.
- Haramaki N, Stewart D, Aggarwal S, Kawabata T, Packer L. "Role of ascorbate in protection by nitecapone against cardiac reperfusion injury." Biochemical Pharmacology. 1995; 50(6): 839-843.